Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cure Pharmaceutical Holding Corp. | 61,654 | reported | 23 Sept 2020 | tx 2+83,233 |
| Profusa, Inc. | 30,000 | reported | 26 Jan 2026 | tx 3+304,660 |
| ADiTx Therapeutics, Inc. | 14,000 | reported | 29 Sept 2021 | tx 2+14,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Jan 2026 | OTHER | Profusa, Inc. | 30,000 | — | |
| 26 Jan 2026 | GRANT_AWARD | Profusa, Inc. | 221,794 | 0.00 USD | deriv |
| 26 Jan 2026 | GRANT_AWARD | Profusa, Inc. | 52,866 | 0.00 USD | deriv |
| 29 Sept 2021 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 11,500 | 0.00 USD | deriv |
| 14 Jul 2021 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 2,500 | 0.00 USD | deriv |
| 06 Aug 2020 | GRANT_AWARD | Cure Pharmaceutical Holding Corp. | 21,579 | 0.00 USD | |
| 23 Sept 2020 | GRANT_AWARD | Cure Pharmaceutical Holding Corp. | 61,654 | 0.00 USD | deriv |